Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Clinical Trials in Italy / NCT06138236
Recruiting Early Phase 1

Plantar Fascitiis: Comparison of ESWT and Collagen Hydrolyzed Peptides

NCT06138236 · tracked via the Priya Life Science Italy tracker
Sponsor
Azienda Ospedaliero-Universitaria Consorziale Policlinico di Bari
Phase
Early Phase 1
Started
2023-07-01
Last updated
2025-12-08

Condition(s) studied

Plantar Fascitis

Investigational drug(s) / intervention(s)

Collagen hydrolyzed peptides

Collagen hydrolyzed peptides: infiltration near the heal spur of 2ml of Arthrys

Study summary

Patients suffering from Plantar Fasciitis were randomized into three groups:

the first group underwent infiltration of Collagen Hydrolyzed Peptides, the second one underwent the ESWT treatment, the third one underwent a combination of the two treatments.

Eligibility

Sex
ALL
Min age
18 Years
Max age
80 Years
Healthy volunteers
No
Inclusion Criteria: Plantar fascitiis Aged between 18 and 80 years old Exclusion Criteria: * Previous surgery of the foot * Contraindications to ESWT

Primary outcome measure(s)

  • VAS (Visuoanalogic scale) — Between recruitment and 30 days
    Visuoanalogic Scale during walking. Range 0 (No pain) -10 (maximum pain)
  • AFAS (American Foot and Ankle Score) is the American Foot and Ankle Scale — Between Recruitment and 15 days
    It is a measurement of active ROM and deambulation of the patient. Range 0 (no function) -100 (perfect function)
  • AFAS is American Foot and Ankle Scale — Between Recruitment and 30 days
    It is a measurement of active ROM and deambulation of the patient (Range 0-100)
  • AFAS is American Foot and Ankle Scale — Between Recruitment and 60 days
    It is a measurement of active ROM and deambulation of the patient (Range 0-100)

Trial sites (1)

FacilityCityRegionStatus
Angela Notarnicola Bari Italy Recruiting

More Azienda Ospedaliero-Universitaria Consorziale Policlinico di Bari trials in Italy

Vey Low-Energy Ketogenic Therapy in Adults With Type 1 Diabetes and Obesity on Intensive Insulin Therapy Using Advanded Hybrid Closed Loop System Recruiting
Treatment for Benign Prostatic Obstruction: Transperineal Laser Ablation Recruiting
RandomizEd ClinicAL triaL on the Efficacy and saFety of Incremental Hemodialysis (REAL-LIFE) Recruiting
High-Energy Laser in the Conservative Treatment of Rhizarthrosis Recruiting
ESWT vs Orthosis in Trigger Finger Enrolling by invitation
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06138236 on ClinicalTrials.gov ↗ ← All trials in Italy